• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Technology Bio Tech

Vection Technologies Share Price Up Again after Health Pivot (ASX:VR1)

Like 0

By Lachlann Tierney, Monday, 21 September 2020

The share price of Vection Technologies Ltd [ASX:VR1] is up again today after announcing a move into healthcare. The VR1 share price is up 22%, trading at 8.3 cents. You can see the VR1 share price lighting up the charts after a long period of sideways trading...

The share price of Vection Technologies Ltd [ASX:VR1] is up again today after announcing a move into healthcare.

The VR1 share price is up 22%, trading at 8.3 cents.

You can see the VR1 share price lighting up the charts after a long period of sideways trading prior to May:

ASX VR1 Share Price Chart - Vection Technologies

Source: Tradingview.com

Here’s a quick look at their latest announcement.

Four Innovative Aussie Stocks that Could Shoot Up Further after Lockdown

VR/AR in Italian hospitals? The opportunity could be bigger than you think

Here’s a quick summary of VR1’s move into healthcare:

  • Deal is with AORN SG Moscati hospital and the Libera Università Internazionale degli Studi Sociali Guido Carli (LUISS)
  • Brings VR1’s Augmented Reality (AR) system to bear on endoscopic equipment and is integrated with electronic medical records
  • Three-month trial

It’s certainly a futuristic idea.

In layman’s terms, you put on the AR goggles and you can see inside the human body and access health records at the same time.

And Italy has around 1,000 hospitals, so a significant addressable market.

The company said they cannot determine the amount of revenue to be derived from the deal but expect it to be material.

Outlook for VR1 share price

In an ideal world, you get in before a breakout.

That being said, I’ve noticed over the last few months an immense appetite for innovative small-caps on the ASX.

This while the market moves sideways, or edges down.

As such, the outlook for the VR1 share price is largely positive.

It’s a good environment out there for small-caps and the strong upwards momentum could be enough to keep it moving forward, even if there is limited positive news flow.

The company also announced $2.6 million in funding from Invitalia and a $1.1 million credit facility prior to today’s announcement.

This would bring the total cash available to around $3–4 million.

A bit light, given the current market cap after the rise in the VR1 share price.

It will be interesting to see whether VR1 goes for a capital raise in the next two quarters and on what terms.

They were cash flow positive last financial year — so there is potential for growth — it’s more a matter of how fast.

Regards,

Lachlann Tierney,
For Money Morning

PS: Four Well-Positioned Small-Cap Stocks: These innovative Aussie companies are well placed to capitalise on post-lockdown megatrends. Click here to learn more.

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments
Lachlann Tierney

Lachlann’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • Don’t Get Swept Up By the Herd: Bulls & Bears in an Age of Social Media
    By Charlie Ormond

    Markets have always reflected this chaotic behaviour, but today’s markets operate in an environment fundamentally transformed by social media.

  • The latest Closing Bell is available now
    By Callum Newman

    Tune in today to watch the latest Closing Bell podcast with Murray Dawes. We discuss gold, oil, real estate…plus a stock to watch. Tune in now!

  • Thorium: One Step Closer to China’s Energy Fortress
    By James Cooper

    Forget AI, the biggest breakthrough of this century will revolve around ENERGY. And the commercialisation of Thorium reactors could be at the heart. Read on to find out why China could be about to make history.

Primary Sidebar

Latest Articles

  • Don’t Get Swept Up By the Herd: Bulls & Bears in an Age of Social Media
  • The latest Closing Bell is available now
  • Thorium: One Step Closer to China’s Energy Fortress
  • The famous yield curve: buy or sell signal? You decide…
  • How Australians voted for a great wealth redistribution

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988